Capital World Investors - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital World Investors ownership history of NEVRO CORP
ValueSharesWeighting
Q4 2022$10,018,800
-15.0%
253,0000.0%0.00%
-33.3%
Q3 2022$11,790,000
+6.3%
253,0000.0%0.00%
+50.0%
Q2 2022$11,089,000
-39.4%
253,0000.0%0.00%
-33.3%
Q1 2022$18,299,000
-10.8%
253,0000.0%0.00%0.0%
Q4 2021$20,511,000
-30.3%
253,0000.0%0.00%
-40.0%
Q3 2021$29,444,000
-29.8%
253,0000.0%0.01%
-28.6%
Q2 2021$41,945,000
+18.8%
253,0000.0%0.01%0.0%
Q1 2021$35,294,000
+27.4%
253,000
+58.1%
0.01%
+40.0%
Q4 2020$27,696,000
+24.3%
160,0000.0%0.01%0.0%
Q3 2020$22,288,000
+16.6%
160,0000.0%0.01%0.0%
Q2 2020$19,115,000
+19.5%
160,0000.0%0.01%0.0%
Q1 2020$15,997,000
-14.9%
160,0000.0%0.01%
+25.0%
Q4 2019$18,806,000
+36.7%
160,0000.0%0.00%
+33.3%
Q3 2019$13,755,000
+32.6%
160,0000.0%0.00%
+50.0%
Q2 2019$10,373,000
+3.7%
160,0000.0%0.00%0.0%
Q1 2019$10,002,000
+60.8%
160,0000.0%0.00%0.0%
Q4 2018$6,222,000
-31.8%
160,0000.0%0.00%0.0%
Q3 2018$9,120,000
-28.6%
160,0000.0%0.00%
-33.3%
Q2 2018$12,776,000
-7.9%
160,0000.0%0.00%0.0%
Q1 2018$13,867,000
+25.5%
160,0000.0%0.00%
+50.0%
Q4 2017$11,046,000
-24.0%
160,0000.0%0.00%
-33.3%
Q3 2017$14,541,000
+22.1%
160,0000.0%0.00%0.0%
Q2 2017$11,909,000
-20.6%
160,0000.0%0.00%
-25.0%
Q1 2017$14,992,000
+55.1%
160,000
-36.0%
0.00%
+33.3%
Q4 2014$9,668,000250,0000.00%
Other shareholders
NEVRO CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,446,333$82,441,0004.44%
Asymmetry Capital Management, L.P. 31,379$1,789,0001.65%
TIRSCHWELL & LOEWY INC 194,470$11,085,0001.38%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 673,480$38,388,0001.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 525,040$29,927,0001.07%
Orbimed Advisors 1,357,691$77,388,0000.93%
Sio Capital Management, LLC 45,091$2,570,0000.88%
PURA VIDA INVESTMENTS, LLC 60,000$3,420,0000.72%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 159,800$9,109,0000.62%
Endurant Capital Management LP 24,171$1,378,0000.61%
View complete list of NEVRO CORP shareholders